Proximal Ventures raises debut fund to back startups bringing AI to drug development (opens techcrunch.com)
Former SignalFire investor Sahir Raoof's first fund targets AI in pharma.
17 stories across editions, newest first.
Former SignalFire investor Sahir Raoof's first fund targets AI in pharma.
Oura buys Counsel Health for $625M weeks after postponing its own IPO; Oura added Counsel's AI chatbot to its app earlier this year.
We help the labs behind your medicines deliver study results 10x faster.
The Alphabet-owned AI drug discovery company would raise roughly $5B at about a $50B valuation, after a $2.1B round in May.
Practice software for vets in Pune that keeps pet owners on doses and boosters after the visit.
Hyderabad's PopVax says its RNA Foundry can turn tumor sequencing data into a personalized mRNA vaccine candidate in eight to ten weeks.
Opentrons will use the money to scale its lab robotics, software and data infrastructure.
Avante says bookings grew nearly fivefold over the past year.
Leash Biosciences built a platform to physically measure thousands of proteins against millions of molecules. In this followup to our Leash Bio podcast with cofounder Ian Quigley, he returns to discuss the release of Minos, Leash’s framework of pre-measured experimental worlds that scientific…
Baba builds AI tools that help Medicare and Medicaid patients connect to care teams and handle advocacy tasks; FirstMark led the round.
The doctor asked what my mom’s sugar level was last year. Simple question. My dad pulled out the plastic bag of reports (you know the one), I scrolled through my gallery, nothing. The test got done again. That annoyed me enough to build something. It’s called KinLab.
The Next Web reports OpenAI and Anthropic will add up to £200m between them to the UK government's £100m lab.
Bristol Myers Squibb led the Series E at a $3 billion valuation.
Kevin Weil, formerly OpenAI's science lead, is building a chemistry contract research organization; TechCrunch says human chemists will train robots for lab tasks.